| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | SEARCH RESULT |
ORIGINAL ARTICLES |
From the VA Health Services Research and Development Center of Excellence on Implementation of Evidence-Based Practices (M.J.B., T.M.D., K.K.), Roudebush VA Medical Center, Indiana University Center for Health Services and Outcomes Research (M.J.B., T.M.D., K.K.), Indianapolis, Indiana; Regenstrief Inc. (M.J.B., T.M.D., K.K.), Indianapolis, Indiana; Department of Medicine (M.J.B., T.M.D., K.K.), Division of Biostatistics (J.W.), Indiana University School of Medicine, Indianapolis, Indiana; Center for The Dartmouth Institute for Health Policy and Clinical Practice (J.M.S.), Dartmouth College, Hanover, New Hampshire.
Address correspondence and reprint requests to Matthew J. Bair, Center of Excellence on Implementation of Evidenced-Based Practices, Roudebush VA Medical Center (11-H) 1481 W. 10th St, Indianapolis, IN 46202. E-mail: mbair{at}iupui.edu
Objective: To assess the relationship between depression and anxiety comorbidity on pain intensity, pain-related disability, and health-related quality of life (HRQL).
Methods: Analysis of baseline data from the Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study. All patients (n = 500) had chronic pain (
3-month duration) of the low back, hip, or knee. Patients with depression were oversampled for the clinical trial component of SCAMP and thus represented 50% of the study population. Patients were categorized according to pain comorbid with depression, anxiety, or both. We used analysis of variance and multivariate analysis of variance models to assess the relationships between independent and dependent variables.
Results: Participants had a mean age of 59 years; they were 55% women, 56% White, and 40% Black. Fifty-four percent (n = 271) reported pain only, 20% (n = 98) had pain and depression, 3% (n = 15) had pain and anxiety, and 23% (n = 116) had pain, depression, and anxiety. Patients with pain and both depression and anxiety experienced the greatest pain severity (p < .0001) and pain-related disability (p < .0001). Psychiatric comorbidity was strongly associated with disability days in the past 3 months (p < .0001), with 18.1 days reported by patients with pain only, 32.2 days by those with pain and anxiety, 38.0 days by those with pain and depression, and 42.6 days in those with all three conditions. We found a similar pattern of poorer HRQL (p < .0001) in those with pain, depression, and anxiety.
Conclusions: The added morbidity of depression and anxiety with chronic pain is strongly associated with more severe pain, greater disability, and poorer HRQL.
Key Words: chronic pain depression anxiety comorbidity outcomes primary care
Abbreviations: ANOVA = analysis of variance; BPI = Brief Pain Inventory; GAD-7 = Generalized Anxiety Disorder 7-item scale; HRQL = health-related quality of life; ICD-9 = International Statistical Classification of Diseases and Related Health Problems, 9th Edition; IU = Indiana University; MANOVA = multivariate analysis of variance; MRI = magnetic resonance imaging; PA = pain and anxiety; PD = pain and depression; PDA = pain, depression, and anxiety; PHQ-9 = Patient Health Questionnaire-9; PO = pain only; SCAMP = stepped care for affective disorders and musculoskeletal pain; SCL-20 = Hopkins Symptom Checklist-20; SF-36 = Medical Outcomes Study Short Form-36; VA = Veterans Affairs.
This article has been cited by other articles:
![]() |
K. E. Freedland, E. J.C. de Geus, R. N. Golden, W. J. Kop, G. E. Miller, V. Vaccarino, B. Brumback, M. M. Llabre, V. J. White, and D. S. Sheps What's in a Name? Psychosomatic Medicine and Biobehavioral Medicine Psychosom Med, January 1, 2009; 71(1): 1 - 4. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | SEARCH RESULT |